127 related articles for article (PubMed ID: 38908967)
1. Long-term cardiovascular outcomes in a population-based multicentric cohort of northern Portugal: Validation of the ESC/EAS prognostic risk classification.
Gavina C; Seabra Carvalho D; Afonso-Silva M; Brandão Abreu D; Canelas-Pais M; Taveira-Gomes T; Araújo F
J Clin Lipidol; 2024 Apr; ():. PubMed ID: 38908967
[TBL] [Abstract][Full Text] [Related]
2. Characterization and LDL-C management in a cohort of high and very high cardiovascular risk patients: The PORTRAIT-DYS study.
Gavina C; Seabra-Carvalho D; Aguiar C; Anastassopoulou A; Teixeira C; Ruivo JA; Almeida É; Luz-Duarte L; Corte-Real A; Canelas-Pais M; Taveira-Gomes T
Clin Cardiol; 2024 Jan; 47(1):e24183. PubMed ID: 37933175
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Risk Profile and Lipid Management in the Population-Based Cohort Study LATINO: 20 Years of Real-World Data.
Gavina C; Carvalho DS; Pardal M; Afonso-Silva M; Grangeia D; Dinis-Oliveira RJ; Araújo F; Taveira-Gomes T
J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431309
[TBL] [Abstract][Full Text] [Related]
4. Statin Use in Primary Prevention of Atherosclerotic Cardiovascular Disease According to 5 Major Guidelines for Sensitivity, Specificity, and Number Needed to Treat.
Mortensen MB; Nordestgaard BG
JAMA Cardiol; 2019 Nov; 4(11):1131-1138. PubMed ID: 31577339
[TBL] [Abstract][Full Text] [Related]
5. Childhood Non-HDL Cholesterol and LDL Cholesterol and Adult Atherosclerotic Cardiovascular Events.
Wu F; Juonala M; Jacobs DR; Daniels SR; Kähönen M; Woo JG; Sinaiko AR; Viikari JSA; Bazzano LA; Burns TL; Steinberger J; Urbina EM; Venn AJ; Raitakari OT; Dwyer T; Magnussen CG
Circulation; 2024 Jan; 149(3):217-226. PubMed ID: 38014550
[TBL] [Abstract][Full Text] [Related]
6. Nationwide cardiovascular risk categorization: applying the European Society of Cardiology guidelines to the Swedish National Diabetes Register.
Eliasson B; Ekelund J; Holmberg CN; Wolden ML; Matthiessen KS; James S
Eur J Prev Cardiol; 2023 May; 30(7):546-551. PubMed ID: 36567502
[TBL] [Abstract][Full Text] [Related]
7. Patterns of Statin Use in a Real-World Population of Patients at High Cardiovascular Risk.
Lin I; Sung J; Sanchez RJ; Mallya UG; Friedman M; Panaccio M; Koren A; Neumann P; Menzin J
J Manag Care Spec Pharm; 2016 Jun; 22(6):685-98. PubMed ID: 27231796
[TBL] [Abstract][Full Text] [Related]
8. Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines.
Mortensen MB; Tybjærg-Hansen A; Nordestgaard BG
JAMA Cardiol; 2022 Aug; 7(8):836-843. PubMed ID: 35793078
[TBL] [Abstract][Full Text] [Related]
9. Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines.
Marston NA; Bonaca MP; Jarolim P; Goodrich EL; Bhatt DL; Steg PG; Cohen M; Storey RF; Johanson P; Wiviott SD; Braunwald E; Sabatine MS; Morrow DA
JAMA Cardiol; 2020 Nov; 5(11):1255-1262. PubMed ID: 32756916
[TBL] [Abstract][Full Text] [Related]
10. ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study.
Mortensen MB; Nordestgaard BG; Afzal S; Falk E
Eur Heart J; 2017 Feb; 38(8):586-594. PubMed ID: 28363217
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register data.
Lindh M; Banefelt J; Fox KM; Hallberg S; Tai MH; Eriksson M; Villa G; Svensson MK; Qian Y
Eur Heart J Qual Care Clin Outcomes; 2019 Jul; 5(3):225-232. PubMed ID: 30649251
[TBL] [Abstract][Full Text] [Related]
12. Associations between β-blocker therapy and cardiovascular outcomes in patients with diabetes and established cardiovascular disease.
Shavadia JS; Zheng Y; Green JB; Armstrong PW; Westerhout CM; McGuire DK; Cornel JH; Holman RR; Peterson ED
Am Heart J; 2019 Dec; 218():92-99. PubMed ID: 31715435
[TBL] [Abstract][Full Text] [Related]
13. Increased FH-Risk-Score and Diabetes Are Cardiovascular Risk Equivalents in Heterozygous Familial Hypercholesterolemia.
Paquette M; Cariou B; Bernard S; Hegele RA; Gallo A; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
Arterioscler Thromb Vasc Biol; 2024 Feb; 44(2):505-512. PubMed ID: 38031840
[TBL] [Abstract][Full Text] [Related]
14. Real-World Risk of Recurrent Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with LDL-C Above Guideline-Recommended Threshold: A Retrospective Observational Study.
Mackinnon ES; Leiter LA; Wani RJ; Burke N; Shaw E; Witges K; Goodman SG
Cardiol Ther; 2024 Mar; 13(1):205-220. PubMed ID: 38285331
[TBL] [Abstract][Full Text] [Related]
15. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
Rosenblit PD
Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
[TBL] [Abstract][Full Text] [Related]
16. Electrocardiography score based on the Minnesota code classification system predicts cardiovascular mortality in an asymptomatic low-risk population.
Kim WD; Lee Y; Kim BS; Kim HJ; Shin JH; Park JK; Park HC; Lim YH; Shin J
Ann Med; 2023; 55(2):2288306. PubMed ID: 38052061
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. Coronary Artery Calcium Score for Long-term Risk Classification in Individuals With Type 2 Diabetes and Metabolic Syndrome From the Multi-Ethnic Study of Atherosclerosis.
Malik S; Zhao Y; Budoff M; Nasir K; Blumenthal RS; Bertoni AG; Wong ND
JAMA Cardiol; 2017 Dec; 2(12):1332-1340. PubMed ID: 29117273
[TBL] [Abstract][Full Text] [Related]
19. A 10- and 15-year performance analysis of ESC/EAS and ACC/AHA cardiovascular risk scores in a Southern European cohort.
Santos-Ferreira C; Baptista R; Oliveira-Santos M; Moura JP; Gonçalves L
BMC Cardiovasc Disord; 2020 Jun; 20(1):301. PubMed ID: 32560700
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
